children with upper respiratory system diseases
Conditions
Interventions
case series:case series
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
All
Age
3 Years to 14 Years
Inclusion criteria
Inclusion criteria: 1. From May 31, 2016 to May 31, 2022 at the target center: outpatient or inpatient cases with Keganliyan oral liquid prescribed; 2. TCM hospitals meet the diagnostic criteria of TCM wind-heat and cold syndrome (not required by western medicine hospitals); 3. Meet the diagnostic criteria of Western medicine for acute upper respiratory tract infection accompanied by pharyngeal swelling and pain; 4. Children aged 3 to 14 years old, regardless of gender.
Exclusion criteria
Exclusion criteria: 1. Cases are combined use of other Chinese patent medicines for the treatment of wind-heat and cold syndrome.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Distribution of patients' drug use and diseases (department, disease diagnosis);Observation of the characteristics of the drug population (demographic characteristics);Clinical application characteristics of Keganliyan oral liquid (dosage, frequency, cycle, combined treatment plan);Adverse events/adverse reactions;Subgroup stratified analysis (record analysis if available, not if not); | — |
Countries
China
Contacts
Public ContactTeng Huang
Outcome results
None listed